PlainRecalls
FDA Drug Low Class III Terminated

Lovastatin Tablets USP, 40 mg, packaged in a) 100-count bottles (NDC 68001-316-00) and b)1000-count bottles (NDC 68001-316-08), Rx Only, Manufactured by: Lupin Limited, Goa 403 722 INDIA For BluePoint Laboratories.

Reported: August 14, 2019 Initiated: February 19, 2019 #D-1584-2019

Product Description

Lovastatin Tablets USP, 40 mg, packaged in a) 100-count bottles (NDC 68001-316-00) and b)1000-count bottles (NDC 68001-316-08), Rx Only, Manufactured by: Lupin Limited, Goa 403 722 INDIA For BluePoint Laboratories.

Reason for Recall

CGMP Deviations: Finished product made with lovastatin drug substance that was out of specification for individual impurity results.

Details

Recalling Firm
American Health Packaging
Units Affected
14,360 bottles
Distribution
Nationwide within the USA and Puerto Rico
Location
Columbus, OH

Frequently Asked Questions

What product was recalled?
Lovastatin Tablets USP, 40 mg, packaged in a) 100-count bottles (NDC 68001-316-00) and b)1000-count bottles (NDC 68001-316-08), Rx Only, Manufactured by: Lupin Limited, Goa 403 722 INDIA For BluePoint Laboratories.. Recalled by American Health Packaging. Units affected: 14,360 bottles.
Why was this product recalled?
CGMP Deviations: Finished product made with lovastatin drug substance that was out of specification for individual impurity results.
Which agency issued this recall?
This recall was issued by the FDA Drug on August 14, 2019. Severity: Low. Recall number: D-1584-2019.